Evidence map›Paper›PMID 41976318›Full record

ArticleCancers2026

Evaluating the Translation Value of Two

Sigrid Cold, Maria Zeiler Alfsen, Brandur Halgirsson, Mads Neergaard Jorgensen, Jacob Hald, Carsten Haagen Nielsen, Andreas Kjaer, Lotte Kellemann Kristensen, Trine Bjornbo Engel

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sigrid ColdMinerva Imaging ApS, 3650 Ølstykke, Denmark.
Maria Zeiler AlfsenMinerva Imaging ApS, 3650 Ølstykke, Denmark.
Brandur HalgirssonMinerva Imaging ApS, 3650 Ølstykke, Denmark.
Mads Neergaard JorgensenMinerva Imaging ApS, 3650 Ølstykke, Denmark.
Jacob HaldMinerva Imaging ApS, 3650 Ølstykke, Denmark.
Carsten Haagen NielsenMinerva Imaging ApS, 3650 Ølstykke, Denmark.
Andreas KjaerCluster for Molecular Imaging, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-2706-5547
Lotte Kellemann KristensenMinerva Imaging ApS, 3650 Ølstykke, Denmark.
Trine Bjornbo EngelMinerva Imaging ApS, 3650 Ølstykke, Denmark.

Funding

Innovation Foundation Denmark 1044-00090B
6 · The paper itself

Abstract

backgroundBreast cancer brain metastases (BCBM) lack effective treatments, contributing to breast cancer-related morbidity and mortality. Integrating translational animal models and advanced non-invasive imaging can accelerate the development of urgently needed therapies.

methodIn this study, we developed an intracarotid method mimicking BCBM and compared it to the stereotactic model in terms of animal welfare, tumour establishment, and blood-brain barrier (BBB) permeability. BCBM was established through intracarotid or stereotactic inoculation of BT474 and MDA-MB-231.Luc2 cells in NMRI nude mice. We utilised magnetic resonance imaging (MRI) and bioluminescence imaging (BLI) to monitor tumour growth and BBB permeability, supported by fluorescent immunohistochemistry for validation. Finally, light sheet microscopy (LSM) was employed to visualise tumour establishment in intact brains.

resultsBoth inoculation methods achieved a survival rate > 70%, with animals recovering within a week post-surgery. MRI and BLI effectively visualised tumour growth with stereotactic implantation, resulting in single tumours, while intracarotid inoculation led to micro-seeding of up to seven tumours in one brain. Tumour growth was rapid and homogenous in the stereotactic model, whereas the intracarotid model exhibited slower, heterogenous growth. Notably, BBB permeability was significantly higher in small tumours in the stereotactic model when compared to the intracarotid model (

conclusionsWe developed an animal model that closely mimics BCBM, highlighting extravasation and micro-seeding while maintaining animal welfare. Our established imaging protocols enable longitudinal evaluations of BBB permeability and treatment response, creating a translational platform for testing novel anti-cancer therapies.

Indexed as

brain metastasisbreast cancerimagingintracarotid inoculationorthotopic model

Identifiers

PMID41976318
PMCPMC13072151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.